Growth-factor and kinase signaling
BPC-157’s reputation rests on healing: tendons, ligaments, gut, skin.
The signaling behind the healing claims
BPC-157’s reputation rests on healing: tendons, ligaments, gut, skin. But healing is just biology, and biology runs on cell signaling. This unit opens the three best-characterized signaling stories behind the claims, from a clean kinase cascade in tendon cells, to a cooperative trick with growth hormone, to a brand-new and unproven idea that might unify them all.
Two things to hold onto: the strongest of these findings still come from cell culture, not humans, and the most exciting of them, the SH3 / Src-kinase model, is a hypothesis-grade preprint. We label the confidence on every step so the elegant ideas never get mistaken for settled facts.
Key terms
FAK and paxillin: the cleanest link
The cleanest mechanistic story in the BPC-157 literature lives inside the cultured rat tendon fibroblast. Chang and colleagues exposed these cells to BPC-157 and watched two proteins light up: focal adhesion kinase (FAK) and paxillin. Both gained phosphate groups in a dose-dependent way while total protein was unaltered, and the cells moved markedly more in a transwell migration assay. Note what the abstract reports: migration through a filter, with no focal-adhesion turnover or wound assay among its readouts. Proliferation was explicitly not affected.
Powerful but preclinical: these are cultured-cell readouts, dose-dependent and clean, and they come from rat tendon cells.
AdvancedFAK and Src are already partners
In general cell biology, not in any BPC-157 paper, FAK autophosphorylation at Y397 builds the very docking site Src binds, and the FAK-Src complex is what phosphorylates paxillin. That detail matters later: if BPC-157 acts upstream on Src itself (the SH3 hypothesis), the FAK-paxillin signal you see here could be a downstream readout of the same event.